Structure Therapeutics Newsroom

Morgan Stanley Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $118

Moomoo NewsNov 15 08:31 ET

Jefferies Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $79

Moomoo NewsNov 14 08:35 ET

BMO Capital Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $100

Moomoo NewsNov 14 07:33 ET

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsNov 14 07:31 ET

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsNov 5 07:37 ET

Piper Sandler Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TipRanksNov 5 07:00 ET

BMO Capital Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $100

Moomoo NewsOct 21 08:31 ET

Cantor Fitzgerald Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $65

Moomoo NewsSep 23 08:33 ET

Structure Therapeutics Analyst Ratings

BenzingaSep 23 08:08 ET

Cantor Fitzgerald Sticks to Their Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TipRanksSep 23 07:59 ET

Morgan Stanley Initiates Structure Therapeutics(GPCR.US) With Buy Rating, Announces Target Price $118

Moomoo NewsSep 23 05:33 ET

Buy Rating for Structure Therapeutics: GSBR-1290's Market Potential in Diabesity

TipRanksSep 23 04:47 ET

Structure Therapeutics Analyst Ratings

BenzingaSep 16 11:50 ET

JMP Securities Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $86

Moomoo NewsSep 10 13:32 ET

Buy Rating on Structure Therapeutics: Promising GSBR-1290 Clinical Developments and Competitive Market Positioning

TipRanksSep 10 12:38 ET

Jefferies Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $79

Moomoo NewsSep 10 08:31 ET

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsSep 10 07:33 ET

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Receives a Buy From Piper Sandler

TipRanksSep 10 06:41 ET

Structure Therapeutics Analyst Ratings

BenzingaAug 19 12:20 ET

Cantor Fitzgerald Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $65

Moomoo NewsAug 15 08:31 ET